Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

• Status: COMPLETED
• Trial end date: 2025-06-09

Summary

The purpose of this study is to evaluate the influence of HRS9531 injection on gastric emptying and pharmacokinetics of metformin, atorvastatin, warfarin, and digoxin in healthy subjects.

• Phase: PHASE1

Details

• Lead Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
• Treatments: Acetaminophen; Atorvastatin; Digoxin; Metformin; Warfarin